Your browser doesn't support javascript.
loading
Doxorubicin-peptide conjugates overcome multidrug resistance.
Mazel, M; Clair, P; Rousselle, C; Vidal, P; Scherrmann, J M; Mathieu, D; Temsamani, J.
Affiliation
  • Mazel M; System, Parc Scientifique Georges Besse, Nimes, France.
Anticancer Drugs ; 12(2): 107-16, 2001 Feb.
Article in En | MEDLINE | ID: mdl-11261883
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Peptides / Brain / Doxorubicin / Drug Resistance, Multiple / K562 Cells Limits: Animals / Humans Language: En Journal: Anticancer Drugs Journal subject: ANTINEOPLASICOS Year: 2001 Document type: Article Affiliation country: Francia Country of publication: Reino Unido
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Peptides / Brain / Doxorubicin / Drug Resistance, Multiple / K562 Cells Limits: Animals / Humans Language: En Journal: Anticancer Drugs Journal subject: ANTINEOPLASICOS Year: 2001 Document type: Article Affiliation country: Francia Country of publication: Reino Unido